Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 13Phase 1 9Phase 1/2 5Phase 2/3 3Phase NA 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 6Recruiting 5Terminated 2Not yet recruiting 2Active not recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Wilms Tumor 1Sarcoma 1Mesothelioma, Malignant 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cervical Adenocarcinoma 1Bone Neoplasms 1Advanced NUT Carcinoma 1

Interventions

pembrolizumab 109Cyclophosphamide 85fludarabine 67Carboplatin 59Injections 58Bevacizumab 52Specimen Handling 42Gemcitabine 41Paclitaxel 40Magnetic Resonance Spectroscopy 40venetoclax 38Nivolumab 38Cisplatin 37Dexamethasone 35Biopsy 34Temozolomide 31Docetaxel 29atezolizumab 27Oxaliplatin 26Capecitabine 26Pemetrexed 25Fluorouracil 25toripalimab 24abemaciclib 24Irinotecan 24Azacitidine 24Fulvestrant 23Rituximab 21fludarabine phosphate 20durvalumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Recruiting × Platinum × Clear all
NCT05019716 2026-05-13

Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma

National Cancer Institute (NCI)

Phase 1/2 Recruiting
36 enrolled

Advanced NUT Carcinoma

NCT03965234 2026-03-17

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Roswell Park Cancer Institute

Phase 1/2 Recruiting
99 enrolled
GastrointestinalSarcoma

Bone Neoplasms, Sarcoma, Colorectal Neoplasms

NCT06543576 2025-08-15

External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer

Jonsson Comprehensive Cancer Center

Phase 1/2 Recruiting
35 enrolled
Gynecologic

Cervical Adenocarcinoma

NCT04278287 2024-12-13

Chemoradiotherapy in Unresectable Esophageal Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1/2 Recruiting
105 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT05765084 2024-05-16

Immuno-MESODEC

University Hospital, Antwerp

Phase 1/2 Recruiting
15 enrolled
GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡